scholarly journals Thrombotic microangiopathy in a kidney transplant patient after COVID-19

Author(s):  
Agnieszka Tarasewicz ◽  
Agnieszka Perkowska-Ptasińska ◽  
Alicja Dębska-Ślizień
2012 ◽  
Vol 79 (1) ◽  
pp. 74-75 ◽  
Author(s):  
Attilio Ignazio Lo Monte ◽  
Maurizio Bellavia ◽  
Carolina Maione ◽  
Giuseppe Damiano ◽  
Maria Concetta Gioviale ◽  
...  

2020 ◽  
Author(s):  
Arturo Bascuñana ◽  
Antonia Mijaylova ◽  
Almudena Vega ◽  
Nicolás Macías ◽  
Eduardo Verde ◽  
...  

2020 ◽  
Vol 35 (6) ◽  
pp. 899-904 ◽  
Author(s):  
Umberto Maggiore ◽  
Daniel Abramowicz ◽  
Marta Crespo ◽  
Christophe Mariat ◽  
Geir Mjoen ◽  
...  

2000 ◽  
Vol 34 (4) ◽  
pp. 536-536 ◽  
Author(s):  
María Outeda Macías ◽  
Pilar Salvador ◽  
Juan L Hurtado ◽  
Isabel Martín

2021 ◽  
Vol 6 (4) ◽  
pp. S314-S315
Author(s):  
G. GEMBILLO ◽  
F. D'Ignoto ◽  
P. Salis ◽  
D. Santoro ◽  
R. Liotta ◽  
...  

2006 ◽  
Vol 6 ◽  
pp. 412-528 ◽  
Author(s):  
Christine Wu ◽  
Parmjeet Randhawa ◽  
Jerry McCauley

BK virus is ubiquitously present in the latent state in humans, and awareness of the importance of BK polyomavirus is emerging among the kidney transplant community. First discovered in 1971 in the urine of a renal transplant recipient, BK virus nephropathy (BKVN) has come to be recognized as a significant cause of genitourinary disease and potential graft loss in the kidney transplant patient. In this review, we discuss the risk factors, available methods of diagnosis and therapeutic monitoring, and current approaches to therapy of BKVN.


2002 ◽  
Vol 97 (5) ◽  
pp. 751-753 ◽  
Author(s):  
Célia MF Gontijo ◽  
Raquel S Pacheco ◽  
Fernando Oréfice ◽  
Euler Lasmar ◽  
Eduardo S Silva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document